Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2024

Month: July

Request Number: A-2022-000927

Request Summary: The latest Periodic Benefit-Risk Evaluation Report (PBRER) submitted to Health Canada for product Tegsedi, marketed in Canada by Akcea Therapeutics Inc.

Disposition: Disclosed in part

Number of pages: 492

Date modified: